Stockholm, November 11, 2024 – Intervacc AB (publ) will publish its interim report for the period January to September 2024 on Thursday 14 November 2024, at 08:30 CET. CEO Jonas Sohlman and CFO Jan Persson will present ... Read more
Stockholm, October 21, 2024 – Intervacc AB (publ) announces that the shortage situation for the equine strangles vaccine Strangvac® in Sweden has been resolved and the vaccine is again in stock for ... Read more
Stockholm, September 20, 2024 - Intervacc AB (publ) predicts that the vaccine Strangvac®, which is approved for sale in Europe and the UK, may be out-of-stock for a short period from the 1st October 2024. The ... Read more
Stockholm, September 20, 2024 – Intervacc AB (publ) announces that the application for supplementary protection for Strangvac®, an innovative vaccine against strangles, has now been approved in the United ... Read more